Loading...
Market
What will be the primary focus of Convergence AI's next major product release by June 30, 2025?
2
Resolution / Starting Odds
Consumer agents • 25%
Enterprise agents • 25%
Healthcare applications • 25%
Other • 25%
Official announcements from Convergence AI
Story
Convergence AI Raises $12M Pre-Seed Round Led by Balderton Capital to Launch Proxy, the First AI Generalist
Sep 25, 2024, 07:00 PM
Convergence AI has announced the successful completion of a $12 million pre-seed funding round, led by Balderton Capital, Salesforce, and Shopify. The company has introduced Proxy, the first AI Generalist, capable of acquiring any skill. Convergence AI has been developing these agents for years, aiming to endow them with long-term memory to enhance their functionality. The pre-seed round funding will support the creation of consumer agents and inform the training of enterprise agents.
View original story
Similar markets
Consumer electronics • 25%
Enterprise solutions • 25%
Healthcare applications • 25%
Other sectors • 25%
Natural Language Processing • 25%
Computer Vision • 25%
Reinforcement Learning • 25%
Other • 25%
Natural Language Processing • 25%
Computer Vision • 25%
Reinforcement Learning • 25%
Other • 25%
AI Risk Assessment Tool • 25%
Compliance Management Platform • 25%
AI Governance Dashboard • 25%
Other • 25%
Natural Language Processing • 25%
Computer Vision • 25%
Robotics • 25%
Other • 25%
New AI search feature • 25%
AI-based advertising platform • 25%
AI-powered analytics tool • 25%
Other major product/service • 25%
Kidney Disease Management • 25%
Infection Treatment • 25%
Cardiovascular Monitoring • 25%
Other • 25%
Consumer device • 25%
Enterprise software • 25%
AI development tool • 25%
Other • 25%
Enhanced Multimodal Capabilities • 25%
Improved User Personalization • 25%
Increased Processing Speed • 25%
Other • 25%
Healthcare • 25%
Finance • 25%
Education • 25%
Other • 25%
Healthcare • 25%
Finance • 25%
Autonomous Vehicles • 25%
Other • 25%
AI reasoning models • 25%
Chatbots • 25%
Healthcare applications • 25%
Other • 25%